RIZZI, Federica Maria Angela
 Distribuzione geografica
Continente #
EU - Europa 2.629
NA - Nord America 2.586
AS - Asia 1.058
OC - Oceania 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
Totale 6.294
Nazione #
US - Stati Uniti d'America 2.534
CN - Cina 859
IT - Italia 601
IE - Irlanda 576
SE - Svezia 415
FI - Finlandia 319
UA - Ucraina 219
DE - Germania 170
RO - Romania 118
TR - Turchia 81
AT - Austria 61
CA - Canada 52
FR - Francia 48
IR - Iran 36
GB - Regno Unito 26
IN - India 25
BE - Belgio 24
SG - Singapore 20
VN - Vietnam 17
CZ - Repubblica Ceca 12
NL - Olanda 11
KR - Corea 8
CH - Svizzera 5
EU - Europa 5
SK - Slovacchia (Repubblica Slovacca) 5
BR - Brasile 4
HK - Hong Kong 4
JP - Giappone 4
AU - Australia 3
EE - Estonia 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
DK - Danimarca 2
ES - Italia 2
GR - Grecia 2
HR - Croazia 2
LU - Lussemburgo 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
NG - Nigeria 1
NP - Nepal 1
PT - Portogallo 1
SC - Seychelles 1
Totale 6.294
Città #
Dublin 572
Chandler 520
Jacksonville 272
Ann Arbor 230
Ashburn 222
Dearborn 211
Parma 187
Beijing 171
Nanjing 145
Focsani 112
Princeton 93
San Mateo 91
Izmir 72
Jinan 60
Vienna 53
Shenyang 49
Wilmington 47
Shanghai 45
Toronto 40
Hebei 39
Nanchang 38
Helsinki 37
Des Moines 34
Changsha 29
Hefei 28
Kunming 27
Leawood 27
Fremont 25
Boardman 23
Brussels 22
Haikou 22
Zhengzhou 22
Guangzhou 21
Milan 20
Falls Church 18
Jiaxing 18
Redmond 18
New York 17
Tianjin 17
Bologna 16
Dong Ket 16
Houston 16
Rome 16
Augusta 15
Seattle 15
Piacenza 13
Taizhou 13
Trieste 13
Ardabil 12
Ardea 12
Taiyuan 12
Bremen 11
Modena 10
Norwalk 10
Chengdu 9
Chicago 9
Monmouth Junction 9
Ningbo 9
Woodbridge 9
Zanjan 9
Carpi 8
Fuzhou 8
Hangzhou 8
Mumbai 8
Padova 8
Grafing 7
Kocaeli 7
Lanzhou 6
Andover 5
Bratislava 5
Brno 5
Fairfield 5
Florence 5
New Delhi 5
Ottawa 5
Pune 5
Sacramento 5
Washington 5
Amsterdam 4
Avellino 4
Brescia 4
Correggio 4
Hong Kong 4
Las Vegas 4
Quzhou 4
Savignano Sul Rubicone 4
Singapore 4
Tokyo 4
Torino 4
Valhalla 4
Wenzhou 4
Brooklyn 3
Düsseldorf 3
Harrisburg 3
Mestre 3
Mongrando 3
Perugia 3
Redwood City 3
Rockville 3
Rovereto 3
Totale 4.137
Nome #
Ionizing Radiation Effects on Hs 578Bst Microtubules 196
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 196
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 138
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 132
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 126
ATTIVITÀ CHEMIO PREVENTIVA DELLE CATECHINE DEL TÈ VERDE NEL CANCRO DELLA PROSTATA 123
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 111
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 105
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 100
A novel transgenic model for prostate cancer displays the tumor-suppressor activity of Clusterin 92
Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis 89
Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development 88
CLU expression negatively modulates prostate cancer progression by inhibiting NF-kB activity 88
The down-regulation of clusterin expression enhances the αsynuclein aggregation process 88
Chronic administration of green tea extract to TRAMP mice induces the collapse ofGolgi apparatus in prostate secretory cells and results in alterations of proteinpost-translational processing. 86
AA Sequencing, Glycosylation and Phosphorylation Site Characterization of Human Serum Clusterin using Liquid Chromatography-High Resolution Mass Spectrometry 85
Effects of CLU over-expression on NF-kB target genes involved in invasion mechanims: preliminary results 84
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 84
Green tea catechins for prostate cancer prevention: Present achievements and future challenges 84
MOLECULAR MECHANISM OF ACTION OF POLYPHENON E, A GREEN TEA EXTRACT, IN BENIGN AND TUMORIGENIC PROSTATE EPITHELIAL CELLS 82
Clinical relevance of green tea catechins on prostate cancer progression in “high risk” men in combination with molecular profiling of catechin-resistant tumors” 81
Chemoprevention of human prostate cancer by green tea catechins: two years later, a follow-up update 79
Clusterin is epigenetically repressed in human prostate cancer cells 77
Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells 77
Chemoprevention of human prostate cancer (PCa) by oral administration of green tea catechins (GTCs) in high grade pin (HGPIN) subjects: a preliminary report from a 1 year proof of principle study 76
Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study 75
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 75
Clusterin as possible biomarker of response to treatment of prostate cancer cells with Polyphenon E 73
Roles of Autophagy Induced by Natural Compounds in Prostate Cancer 71
Flexible PBAT-Based Composite Filaments for Tunable FDM 3D Printing 70
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins (GTCs) in High Grade PIN Volunteers: a Preliminary Report from a 1 Year Proof-of-Principle Study 70
CLUSTERIN IS EPIGENETICALLY REPRESSED IN HUMAN PROSTATE CANCER CELLS 70
Molecular targets of (-)-Epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts 70
Le catechine estratte dal tè verde per la prevenzione del tumore della prostata 69
Deciphering the role of the molecular chaperone clusterin on α-synuclein aggregation. 69
Clusterin (CLU): From one gene and two transcripts to many proteins 67
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 67
Chronic Administration of Green Tea Extracts in TRAMP Mice Reduces the Activity of the Secretory Pathway Causing an Imbalance of the Protein Trafficking 67
Clusterin: an “enigmatic” protein that turns to a novel tumour-suppressor gene 66
EGCG antagonizes Bortezomib-, but not MG132-induced cell death in prostate cancer cells 66
Clusterin (CLU) and lung cancer 65
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 65
Chemoprevention of human prostate cancer by oral administration of green tea catechins 65
Clusterin (CLU) and prostate cancer 64
Upregulation of Clusterin in Prostate and DNA Damage in Spermatozoa from Bisphenol A-Treated Rats, and Formation of DNA Adducts in Cultured Human Prostatic Cells 63
The role of clusterin on alpha-synuclein aggregation in an “in vitro” model of Parkinson disease 63
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 63
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 62
Inhibitory Effects of Green Tea Catechins on Prostate Cancer progression 61
EFFECT OF COLD PLASMA TREATMENT ON THE FUNCTIONAL PROPERTIES OF FRESH-CUT APPLES 61
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 60
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 60
Role of Clusterin in normal or tumoral bronchial human cells exposed to cigarette smoke 60
Effects of Clusterin knock down on prostate cancer progression in the tramp model 59
Human Prostate Cancer Prevention by Green Tea Catechins:Clinical Trial and Putative Molecular Mechanism of Action 59
Effect of cold plasma treatment on physico-chemical parameters and antioxidant activity of minimally processed kiwifruit 58
Clinical relevance of the inhibitory effect of Green Tea Catechins (GTCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view 58
Anticancer activity of green tea polyphenols in prostate gland 57
Determination of the level of expression of ODC, AdoMetDC, OAZ and SSAT for molecular classification of Green Tea Catechins-sensitive and –resistant Prostate Cancer in the TRAMP mice model by q-PCR gene profiling 57
Sviluppo di un metodo in Real Time PCR per la diagnosi e la prognosi molecolare del carcinoma prostatico umano 57
Molecular classification of Green Tea Catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 56
Development of a green fluorescent reporter for the bio-assay of anti-cancer drugs with anti-oxidant activity 56
Molecular diagnosis of human prostate cancer (CaP) by RT-qPCR determination of gene expression signature 56
Epigenetic regulation of clusterin transcriptional variants in normal, immortalized and cancerous human cell lines 55
Espressione in forma ricombinante di differenti forme di clusterina 54
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 54
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 53
Clusterin gene expression as a novel biomarker of response to chemoprevention with GTE in humans 52
Development of a green fluorescent reporter plasmid for the bio-assay of anti-oxidant compounds 51
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model 51
Clusterin is epigenetically repressed in human prostate cancer. 50
Redox Status and Proteostasis in Ageing and Disease 50
The tumor-suppressor activity of Clusterin (CLU) is fully displayed in a novel transgenic model for prostate cancer: the TRAMP/CluKO mice model 50
Il tè verde nella chemoprevenzione oncologica 49
The Clusterin Paradigm in Prostate and Breast Carcinogenesis 49
Identification and characterization of a novel promoter of the CLU gene which drives the expression of a rare CLU mRNA variant in PCa cells following administration of epigenetic drugs. 49
Molecular classification of green tea catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative RT real-time PCR gene profiling 48
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer 48
Inhibition of human prostate cancer progression by administration of green tea catechins: a two years later follow-up update 47
Effect of plasma exposure time on the polyphenolic profile and antioxidant activity of fresh-cut apples 47
Platelets contribute to amyloid-b aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release 46
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment 46
Experimental development of a novel molecular tool for human prostate cancer (CaP) diagnosis by RT-qPCR determination of gene expression signature 45
Targeting clusterin in prostate cancer 42
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 42
Gene signature of TRAMP mice tumors for classification of Green Tea Catechins –sensitive and –resistant prostate cancer 42
Clusterin is a very short half-life, poly-ubiquitinated protein controlling cell growth and proliferation in prostate cancer metastatic cells 41
Green tea polyphenols and prostate cancer chemoprevention 40
Nuclear CLU (nCLU) and the fate of the cell 38
Prognostic role of clusterin in resected adenocarcinomas of the lung 35
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells 33
HUMAN PROSTATE CANCER PREVENTION BY GREEN TEA CATECHINS: THE CLINICAL TRIAL AND PUTATIVE MOLECULAR MECHANISMS OF ACTION 30
Study on the quality and stability of minimally processed apples impregnated with green tea polyphenols during storage 28
Clusterin Expression and Localization Are Affected by Rituximab and Doxorubicin Treatment in Non-Hodgkin Lymphoma Cells and B Lymphocytes 28
Oxidative Stress, Chronic Inflammation, and Amyloidoses 20
Unexpected Absence of Skeletal Responses to Dietary Magnesium Depletion: Basis for Future Perspectives? 13
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 8
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 4
SERS-based methods for the detection of genomic biomarkers of cancer 3
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 2
Totale 6.440
Categoria #
all - tutte 19.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019127 0 0 0 0 0 0 0 0 0 10 108 9
2019/20201.439 183 193 60 67 104 187 168 31 90 258 23 75
2020/2021986 5 62 53 30 228 53 78 49 159 47 184 38
2021/2022571 22 46 8 16 29 16 71 75 26 44 67 151
2022/20232.055 186 208 155 173 137 232 22 137 669 14 82 40
2023/2024563 63 53 30 24 88 148 49 43 23 42 0 0
Totale 6.440